Dow Down 0.25% Nasdaq Up 0.24%

Immunomedics Inc. (IMMU)

-NasdaqGM
3.28 Down 0.05(1.50%) 2:58PM EDT - Nasdaq Real Time Price
Prev Close:3.33
Open:3.33
Bid:3.27 x 5800
Ask:3.28 x 6300
1y Target Est:7.00
Beta:0.71
Next Earnings Date:N/A
Day's Range:3.22 - 3.33
52wk Range:3.04 - 7.35
Volume:239,277
Avg Vol (3m):524,429
Market Cap:305.41M
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMU

Comparison

Symbol% ChgMkt Cap
IMMUDown 1.50%305.41M
BIIBDown 0.35%80.72B
GSKDown 1.87%115.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):34.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.52
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback